Literature DB >> 3038009

Prooxidative activities of 10 phenazine derivatives relative to that of clofazimine.

B M Zeis, R Anderson, J F O'Sullivan.   

Abstract

The objective of this study was to investigate the relationship between the antimycobacterial properties of the antileprosy drug clofazimine and its stimulatory effect on the release of reactive oxidants by polymorphonuclear leukocytes by using a variety of phenazine derivatives. The effects of these compounds on myeloperoxidase-mediated iodination, luminol-enhanced chemiluminescence, and the release of superoxide anion by polymorphonuclear leukocytes were investigated. Dissociation of the antimycobacterial and prooxidative effects of clofazimine was possible by manipulation of the chemical group in position 2 of the phenazine molecule. When nitrogen-containing substituents in this position were replaced by oxygen, the mode of the prooxidative action of the compounds was altered.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038009      PMCID: PMC174834          DOI: 10.1128/AAC.31.5.789

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Rimino-phenazines and the reticulo-endothelial system.

Authors:  M L Conalty
Journal:  Ir J Med Sci       Date:  1966-11       Impact factor: 1.568

2.  An appraisal of the technique of polymorphonuclear leukocyte chemiluminescence as a means to detect compounds with antiinflammatory activity.

Authors:  J Bird; J P Giroud
Journal:  J Pharmacol Methods       Date:  1985-12

3.  Pharmacology of free radicals; recent views on their relation to inflammatory mechanisms.

Authors:  F Hertz; A Cloarec
Journal:  Life Sci       Date:  1984-02-20       Impact factor: 5.037

4.  Antitubercular substances. XXII. Rimino-phenazines--the effect of further substitution.

Authors:  V C Barry; J G Belton; M L Conalty; M McInerney
Journal:  Proc R Ir Acad B       Date:  1970

5.  The in vitro effects of propranolol and atenolol on neutrophil motility and post-phagocytic metabolic activity.

Authors:  R Anderson; A J van Rensburg
Journal:  Immunology       Date:  1979-05       Impact factor: 7.397

6.  Antituberculosis activity in the phenazine series. II. N3-substituted anilinoaposafranines (rimino-compounds) and some derivatives.

Authors:  V C BARRY; M L CONALTY
Journal:  Am Rev Tuberc       Date:  1958-07

Review 7.  Lamprene (clofazimine) in leprosy. Basic information.

Authors:  S J Yawalkar; W Vischer
Journal:  Lepr Rev       Date:  1979-06       Impact factor: 0.537

8.  Tissue concentrations of clofazimine (B663) in man.

Authors:  R E Mansfield
Journal:  Am J Trop Med Hyg       Date:  1974-11       Impact factor: 2.345

9.  Susceptibility of Mycobacterium leprae to the bactericidal activity of mouse peritoneal macrophages and to hydrogen peroxide.

Authors:  A K Sharp; M J Colston; D K Banerjee
Journal:  J Med Microbiol       Date:  1985-02       Impact factor: 2.472

10.  Myeloperoxidase-mediated iodination by granulocytes. Intracellular site of operation and some regulating factors.

Authors:  R K Root; T P Stossel
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

View more
  2 in total

1.  Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species.

Authors:  Takahiro Yano; Sacha Kassovska-Bratinova; J Shin Teh; Jeffrey Winkler; Kevin Sullivan; Andre Isaacs; Norman M Schechter; Harvey Rubin
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

2.  The inhibitory effects of Mycobacterium tuberculosis on MHC class II expression by monocytes activated with riminophenazines and phagocyte stimulants.

Authors:  A A Wadee; R H Kuschke; T G Dooms
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.